[Pharmacokinetics of rifampicin administered intravenously to pulmonary tuberculosis patients]. 1987

A V Ziia, and G B Sokolov, and A A Firsov

Pharmacokinetics of rifampicin studied in 15 patients after its intravenous administration in a dose of 10 mg/kg was described by a two-compartment model. The drug levels in serum and urine were determined with a chemical method. At the moment of the infusion discontinuation the maximum drug levels in serum averaged to 14.05 micrograms/ml. The mean values of the total clearance, distribution of the kinetic volume and half-lives were 93.2 ml/(h X kg), 1016.1 ml/kg and 8.1 h respectively. Cumulative excretion of the total rifampicin within 24 hours amounted to 19.4 per cent of the administered dose, the proportions of the main metabolite (25-O-desacetyl rifampicin) and intact rifampicin being equal to 29 and 71 per cent respectively. The renal and nonrenal clearance of rifampicin amounted to 14.2 and 79 ml/(h X kg) respectively.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

A V Ziia, and G B Sokolov, and A A Firsov
April 1977, Problemy tuberkuleza,
A V Ziia, and G B Sokolov, and A A Firsov
December 1988, Vrachebnoe delo,
A V Ziia, and G B Sokolov, and A A Firsov
June 1986, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
A V Ziia, and G B Sokolov, and A A Firsov
May 2016, Journal of clinical pharmacology,
A V Ziia, and G B Sokolov, and A A Firsov
May 2020, Drug research,
A V Ziia, and G B Sokolov, and A A Firsov
October 1985, Journal of pharmaceutical sciences,
A V Ziia, and G B Sokolov, and A A Firsov
September 1992, Research in veterinary science,
A V Ziia, and G B Sokolov, and A A Firsov
January 1978, Anesthesia and analgesia,
A V Ziia, and G B Sokolov, and A A Firsov
August 1984, Antimicrobial agents and chemotherapy,
A V Ziia, and G B Sokolov, and A A Firsov
January 2005, The Pediatric infectious disease journal,
Copied contents to your clipboard!